Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ariagno

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Pediatrics|August 1, 1985
Near-miss sudden infant death syndrome in eight infants with sleep apnea-related cardiac arrhythmiasC Guilleminault, R Ariagno, S Coons, et al.
Pediatrics|December 1, 1979
Mixed and obstructive sleep apnea and near miss for sudden infant death syndrome: 2. Comparison of near miss and normal control infants by ageC Guilleminault, R Ariagno, R Korobkin, et al.
The Pediatric Infectious Disease Journal|March 11, 1998
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study GroupK N Subramanian, L E Weisman, T Rhodes, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Pediatrics|August 1, 1985
Near-miss sudden infant death syndrome in eight infants with sleep apnea-related cardiac arrhythmiasC Guilleminault, R Ariagno, S Coons, et al.
Pediatrics|December 1, 1979
Mixed and obstructive sleep apnea and near miss for sudden infant death syndrome: 2. Comparison of near miss and normal control infants by ageC Guilleminault, R Ariagno, R Korobkin, et al.
The Pediatric Infectious Disease Journal|March 11, 1998
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study GroupK N Subramanian, L E Weisman, T Rhodes, et al.
Pageof 2